Join
Live feed
·
INSIDERFilingvia Quantisnow
Sarepta Therapeutics Inc. logo

Chief Executive Officer Severino Michael was granted 756,104 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SRPT· Sarepta Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRPT (Sarepta Therapeutics Inc.) and more on Quantisnow.

Chief Executive Officer Severino Michael was granted 756,104 shares (SEC Form 4) | Quantisnow